arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Jaguar Health, Inc.

JAGX
$0.40 ▼ -0.09 (-17.69%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
51 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
9
Health
Poor
Bearish
auto_awesome

Analytical Summary

Jaguar Health, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth -58.9% ↘
Op. Margin None
ROIC None
FCF / Share $-6.60 ↘
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

51-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.23M
↓ -58.9% —
Net Income Profit after all expenses
$-12.80M
↓ -23.0% —
Operating Margin Operating profit as % of sales
50.2%
↑ +121.4% 0th
FCF / Share Free cash flow per share
$-6.60
↓ -101.1% —
Long-Term Debt Long-term obligations
$10.77M
↓ -1.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
0
Financial Health ↓
5
Cash Quality ↓
37

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 13 years · 51 quarters